Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Visionflex GroupASX:VFX EV-to-EBITDA is -2.62 as of Jul. 28, 2026. The stock has 6 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Visionflex Group ranks worse than 196463.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Visionflex Group's enterprise value is A$4.03 Mil.
Visionflex Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.54 Mil. Therefore, Visionflex Group's EV-to-EBITDA for today is -2.62.
The historical rank and industry rank for Visionflex Group's EV-to-EBITDA or its related term are showing as below:
ASX:VFX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -10.76 Med: -1.9 Max: 1.03
Current: -2.62
During the past 11 years, the highest EV-to-EBITDA of Visionflex Group was 1.03. The lowest was -10.76. And the median was -1.90.
ASX:VFX's EV-to-EBITDA is ranked worse than 100% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.03
vs ASX:VFX: -2.62
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Visionflex Group (ASX:VFX) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Visionflex Group's PE Ratio (TTM) for today is calculated as:
Visionflex Group's share price for today is A$0.058.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visionflex Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.017.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Visionflex Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:VFX vs VEEV, BTSG, HQY: EV-to-EBITDA Comparison
For the Health Information Services subindustry, Visionflex Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visionflex Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Visionflex Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Visionflex Group's EV-to-EBITDA falls into.
Visionflex Group's current Enterprise Value is A$4.03 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visionflex Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Visionflex Group (ASX:VFX) has a EV-to-EBITDA of -2.62 as of Jul. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Visionflex Group. According to the industry distribution chart, Visionflex Group ranks #999999 out of 509 companies in the Healthcare Providers & Services industry.
Is Visionflex Group's EV-to-EBITDA too high?
Visionflex Group's current EV-to-EBITDA is -2.62. Based on the distribution chart, Visionflex Group ranks #999999 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Visionflex Group's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Visionflex Group ranks #999999 out of 509 companies for EV-to-EBITDA. This places Visionflex Group in the lower half of its industry. The industry median EV-to-EBITDA is 11.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.03, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Visionflex Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visionflex Group's current EV-to-EBITDA is -2.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visionflex Group stock overvalued right now?
Based on GuruFocus' analysis, Visionflex Group (ASX:VFX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.07, compared to a current price of A$0.06 — trading 17.1% below its estimated fair value. The current EV-to-EBITDA is -2.62. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Visionflex Group (ASX:VFX), the current EV-to-EBITDA is -2.62 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Visionflex Group Ltd is an online health portal group. The company is engaged in the provision of health care and corporate online search and appointment booking services. The group has three operating segments: Visionflex, Legacy 1ST Group Booking Businesses, and Corporate head office. The company generates the majority of its revenue from the Visionflex segment, which is engaged in Virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. Legacy 1ST Group Businesses is engaged in the provision of healthcare and corporate online search and appointment booking services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VFX has been successfully added to your 
